|
TIMELESS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.721210E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.850000E-02 |
| Normal-vs-Stage2 |
2.048800E-01 |
| Normal-vs-Stage3 |
7.167600E-01 |
| Normal-vs-Stage4 |
9.080200E-01 |
| Stage1-vs-Stage2 |
9.914000E-01 |
| Stage1-vs-Stage3 |
1.312050E-01 |
| Stage1-vs-Stage4 |
1.244610E-01 |
| Stage2-vs-Stage3 |
2.985400E-01 |
| Stage2-vs-Stage4 |
2.594200E-01 |
| Stage3-vs-Stage4 |
8.160800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.855500E-02 |
| Normal-vs-AfricanAmerican |
4.846600E-01 |
| Normal-vs-Asian |
4.643600E-01 |
| Caucasian-vs-AfricanAmerican |
7.744600E-01 |
| Caucasian-vs-Asian |
5.144400E-01 |
| AfricanAmerican-vs-Asian |
9.085400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.586000E-01 |
| Normal-vs-Female |
9.530100E-02 |
| Male-vs-Female |
1.035770E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.734000E-02 |
| Normal-vs-Age(41-60Yrs) |
6.272600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.505800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.336000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.651900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.710800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.225400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.764000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.082800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.430600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.766400E-01 |
| Classical-VS-Follicular |
4.061600E-01 |
| Classical-VS-Other |
1.898200E-01 |
| Classical-VS-Normal |
1.090790E-01 |
| Tall-VS-Follicular |
8.979000E-01 |
| Tall-VS-Other |
2.856600E-01 |
| Tall-VS-Normal |
4.750000E-01 |
| Follicular-VS-Other |
4.894800E-01 |
| Follicular-VS-Normal |
5.630800E-01 |
| Other-VS-Normal |
4.741600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.284200E-01 |
| Normal-vs-N1 |
9.392200E-01 |
| N0-vs-N1 |
2.564000E-01 |
|
|
